Jump to Subnavigation

Service Navigation

Biotech start-ups

Start-ups in the spotlight

The German start-up scene in the biotech sector is growing. There is a wide range of young biotech companies that develop new therapies and diagnostics or offer other industrial biotech processes and services for various industry branches in the chemical, food or materials sectors. Here you will find a selection of interesting newcomers.


Esencia, the startup helping to feed 10 billion people by rethinking fish and seafood.

Leading researchers in dermatology, molecular biology, microfluidics and artificial intelligence have joined forces to help patients suffering from skin diseases and stigma receive accurate diagnoses and improve their quality of life.

SciRhom's anti-iRhom2 antibodies represent a promising new approach to more effectively treat various diseases, including major autoimmune diseases such as rheumatoid arthritis.

TolerogenixX is a biopharmaceutical company focused on the development of novel, personalized therapies for patients with autoimmune disorders and transplant recipients.

Düsseldorf-based Abalos Therapeutics GmbH uses the unique immune stimulation of arena viruses to develop a new approach to fight cancer.

advanceCOR GmbH from Bavaria specialises in innovative drugs for the personalized treatment of cardiovascular diseases. The most advanced therapy candidate is for the preventive treatment of strokes and heart attacks.

Berlin-based Aignostics GmbH has set itself the goal of revolutionising and digitising pathology with the help of artificial intelligence.

Atriva Therapeutics GmbH, based in Baden-Württemberg, develops therapies for the treatment of serious viral diseases like COVID-19 and influenza.

Berlin-based Bluu Biosciences GmbH is the first European biotech company focusing on the development of cultivated fish.

Cardior Pharmaceuticals GmbH from Hannover is pioneering the discovery and development of RNA-based therapeutics designed to prevent, repair and reverse diseases of the heart.

CatalYm is a Munich-based immunotherapy pioneer developing antibody therapeutics for patients with solid tumors.

Braunschweig-based CORAT Therapeutics GmbH developed an antibody-based COVID-19 treatment which is currently in phase Ib/II clinical testing.

Berlin-based Formo GmbH is specialised in the manufacturing of vegan cheese products. The company uses precision fermentation to create animal-free milk proteins, which they turn into cheeses in the artisan tradition.

Noscendo GmbH from North Rhine-Westphalia has developed a digital precision diagnostic platform which identifies more than 1,500 pathogens in just a few hours using a blood sample.

Düsseldorf-based Numaferm GmbH relies on disruptive technologies to produce recombinant peptides and proteins at scale, at purity and cost needed.

Freiburg-based Spindiag GmbH has developed a mobile point-of-care rapid test system for SARS-CoV-2 that delivers results directly on the device in well under one hour.

Hamburg-based Topas Therapeutics GmbH aims at treating autoimmune diseases more precisely – with the help of special nanoparticle-based therapeutics.

Hamburg-based start-up traceless materials GmbH has developed a advanced natural material alternative for plastics and bioplastics that is 100% biocircular and holistically sustainable, and thus contributes to solving global plastic pollution.

Stay informed!

We send the BIOTECH Insight Newsletter four times a year. Register now and receive sector-relevant updates regularly by e-mail.

© Deutsche Börse Cash Market